There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories.
The early diagnosis of Alzheimer disease is a boon in that it enables advance planning, but that planning process can engender conflict between respect for future-oriented autonomy and future welfare.
This month, Virtual Mentor spoke with Dr. Alex Ding and Mr. Jordan VanLare, a fourth-year medical student at Columbia University College of Physicians and Surgeons, about their impressions of health reform and how it will impact the medical practice environment they will soon enter.
This month, Virtual Mentor spoke with Dr. Peter W. Carmel to discuss health reform and, specifically, why the AMA supports the full repeal of the formula used to calculate Medicare payments to physicians.
A consensus has emerged that the paternalism behind use of the provocative saline infusion test for nonepileptic seizures cannot be justified because the harms to the patient, the physician, and their relationship exceed the benefits.
The Supreme Court’s ruling in Riegel v. Medtronic, Inc., may prevent consumers injured by medical devices that have FDA premarket approval from receiving compensation.